Neil Gibson, Ph.D.
Vice President and Chief Scientific Officer

Dr. Gibson, is the Chief Scientific Officer of OSI Pharmaceuticals.. In this role he serves as the scientific expert on the Executive Management Committee providing both technical and strategic advice. He works closely with the oncology and diabetes teams heads to identify opportunities for research collaboration between the two areas of focus and with the business development teams to optimize our business development strategies. Dr. Gibson is also responsible for advocating OSI's science to the investment community, as well as continuing to manage the core research activities in the company.

Dr. Gibson has also served as Vice President of Research (2002 - 2005) and Vice President of U.S. Research (2002) at OSI Pharmaceuticals. Dr. Gibson began his career with OSI in January 2001 as Senior Director, Cancer Discovery. Dr. Gibson's experiences, prior to joining OSI, include serving as the Director for Cancer Research, Department of Cancer and Osteoporosis at Bayer Corporation; Senior Research Investigator at Pfizer Inc. during which he played an integral role in the Pfizer/OSI cancer collaboration; Associate Professor, School of Pharmacy and Comprehensive Cancer Center University of Southern California; and Fogarty Fellow at the National Cancer Institute, National Institutes of Health.

During his career Dr. Gibson has served on the Experimental Therapeutics Study Section of the National Cancer Institute, has been actively involved with the American Association of Cancer Research and is Past President of the British Pharmaceuticals Students Association.